A novel hypothesis regarding the possible involvement of cytosolic phospholipase 2 in insulin-stimulated proliferation of vascular smooth muscle cells

Cell Biology International

Volumn 33, Issue 3, 2009, Pages 386-392

  Isenovic, Esma R ^a   Fretaud, Maxence ^b   Dobutovic, Branislava ^a   Sudar, Emina ^a   Smiljanic, Katarina ^a   Zaric, Bozidarka ^c   Trpkovic, Andreja ^a   Marche, Pierre ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CNRS   (France)

^c Institute for Chemistry   (Serbia)

Author keywords

cPLA2; ERK1 2; INS; PI3K; Proliferation; Vascular smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ARACHIDONIC ACID; CYTOSOLIC PHOSPHOLIPASE A2; FLUOROPHOSPHATE; INSULIN; METHYLARACHIDONYLFLUOROPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ARACHIDONIC ACID; CELL PROLIFERATION; CELLS, CULTURED; ENZYME INHIBITORS; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHORYLATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 61349124153     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.01.010     Document Type: Article

References (44)

1. Anderson K.M., Roshak A., Winkler J.D., McCord M., and Marshall L.A. Cytosolic 85-kDa Phospholipase A2-mediated Release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J Biol Chem 272 (1997) 30504-30511
2. 2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells. J Biol Chem 272 (1997) 8576-8580
3. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2581
4. Bobe R., Yin X., Roussanne M.C., Stepien O., Polidano E., Faverdin C., et al. Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation. Am J Physiol Heart Circ Physiol 285 (2003) 745-754
5. Campbell J.H., Black M.J., and Campbell G.R. Replication of smooth muscle vessel cells in atherosclerosis and hypertension. In: Meyer P., and Marche P. (Eds). Blood cells and arteries in hypertension and atherosclerosis (1989), Raven Press, New York 15-33
6. Carpenter C.L., and Cantley L.C. Phosphoinositide 3-kinase and the regulation of cell growth. Biochim Biophys Acta 1288 (1996) 11-16
7. 2 from the human monocytic cell line U937. Proc Natl Acad Sci U S A 87 (1990) 7708-7712
8. Colwell J.A., and Jokl R. Vascular thrombosis in diabetes. In: Porte D., Sherwin R., and Rifkin H. (Eds). Diabetes mellitus: theory and practice (1996), Appleton and Lange, Norwalk 207-216
9. Colwell J.A., Lyons T.J., Klein R.L., and Lopes-Virella M. New concepts about the pathogenesis of atherosclerosis and thrombosis in diabetes mellitus. In: Levin M.J. (Ed). The diabetic foot (1992), Mosby, St. Louis 79-114
10. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by INS mediated by protein kinase B. Nature 378 (1995) 785-789
11. Cusi K., Maezono K., Osman A., Pendergrass M., Patti M.E., Pratipanawatr T., et al. INS resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105 (2000) 311-320
12. Downes C.P., and Carter A.N. Phosphoinositide 3-kinase: a new effector in signal transduction?. Cell Signal 3 (1991) 501-513
13. Folli F., Kahn C.R., Hansen H., Bouchie J.L., and Feener E.P. Angiotensin II inhibits INS signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in INS/angiotensin II cross-talk. J Clin Invest 100 (1997) 2158-2169
14. Freeman E.J., Ruehr M.L., and Dorman R.V. ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. Am J Physiol: Cell Physiol 274 (1998) 282-288
15. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 62 (1982) 347-504
16. Fukuda N., Satoh C., Hu W.Y., Nakayama M., Kishioka H., and Kanmatsuse K. Endogenous angiotensin II suppresses INS signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 19 (2001) 1651-1658
17. Gluck N., Schwob O., Krimsky M., and Yedgar S. Activation of cytosolic phospholipase A2 and fatty acid transacylase is essential but not sufficient for thrombin-induced smooth muscle cell proliferation. Am J Physiol Cell Physiol 294 (2008) 1597-1603
18. Iouzalen L., Stepien O., and Marche P. Effects of BAY 10-6734 (embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth. J Pharmacol Exp Ther 289 (1999) 1817
19. Isenovic E.R., Meng Y., Divald A., Milivojevic N., and Sowers J.R. Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and INS-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells. Endocrine 19 (2002) 287-292
20. +-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells. Int J Mol Med 13 (2004) 915-922
21. + pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells. Endocrinology 145 (2004) 1151-1160
22. Isenovic E.R., Fretaud M., Koricanac G., Sudar E., Velebit J., Dobutovic B., et al. Insulin regulation of proliferation involves activation of Akt and Erk1/2 signaling pathways in vascular smooth muscle cells. Exp Clin Endocrinol Diabetes 116 (2008) 1-6
23. 2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem 266 (1991) 5268-5272
24. LaPointe M.C., and Isenovic E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33 (1999) 276-282
25. Lin L., Lin A.Y., and DeWitt D.L. Enzymic activities of two-chain pepsinogen, two-chain pepsin, and the amino-terminal lobe of pepsinogen. J Biol Chem 267 (1992) 23451-23454
26. 2 is phosphorylated and activated by MAP kinase. Cell 72 (1993) 269-278
27. Longo W.E., Grossmann E.M., Erickson B., Panesar N., Mazuski J.E., and Kaminski D.L. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells. J Surg Res 84 (1999) 51-56
28. Montagnani M., Golovchenko I., Kim I., Koh G.Y., Goalstone M.L., Mundhekar A.N., et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of INS in endothelial cells. J Biol Chem 277 (2002) 1794-1799
29. Mulvany M.J., Hansen O.K., and Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 43 (1978) 854-864
30. Muthalif M.M., Benter I.F., Karzoun N., Fatima S., Harper J., Uddin M.R., et al. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci U S A 95 (1998) 12701-12706
31. Myers M.G., Backer J.M., Sun X.J., Shoelson S., Hu P., Schlessinger J., et al. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci U S A 89 (1992) 10350-10354
32. 2. EMBO J 11 (1992) 4917-4922
33. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett 261 (1990) 171-174
34. 2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem 266 (1991) 9956-9960
35. Payne D.M., Rossomando A.J., Martino P., Erickson A.K., Her J.H., Shabanowitz J., et al. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10 (1991) 885-892
36. Saward L., and Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81 (1997) 249-257
37. 2 activity and growth in vascular smooth muscle cells. Arch Biochem Biophys 402 (2002) 84-93
38. Stout R.W. Insulin and atherogenesis. Eur J Epidemiol 8 (1992) 134-135
39. Sudar E., Velebit J., Gluvic Z., Zakula Z., Lazic E., Vuksanovic-Topic L., et al. Hypothetical mechanism of sodium pump regulation by estradiol under primary hypertension. J Theor Biol 251 (2008) 584-592
40. Taha C., and Klip A. The INS signaling pathway. J Membr Biol 169 (1999) 1-12
41. 2 contains eight ankyrin motifs. J Biol Chem 272 (1997) 8567-8575
42. 2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension 23 (1994) 931-935
43. Yin X., Polidano E., Faverdin C., and Marche P. Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. J Hypertens 23 (2005) 337-350
44. Zakula Z., Koricanac G., Putnikovic B., Markovic L., and Isenovic E.R. Regulation of the inducible nitric oxide synthase and sodium pump in type 1 diabetes. Med Hypotheses 69 (2007) 302-306